Labshake search
Citations for R&D Systems :
401 - 450 of 2608 citations for Recombinant Human EGFR Protein His Avi tagged Biotinylated since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human FGF basic146 aa (10 ng/ml, R&D Systems) for another 2 weeks as previously described37.
-
Phospholipase C β4 promotes RANKL-dependent osteoclastogenesis by interacting with MKK3 and p38 MAPKbioRxiv - Cell Biology 2024Quote: Recombinant human RANKL was purchased from R&D Systems (Minneapolis, MN, USA), and M-CSF was obtained from PeproTech (Rocky Hill ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Immunology 2021Quote: The expression of NKG2D ligands in tumor cell lines was assessed using Recombinant Human NKG2D Fc Chimera Protein (R&D systems, Abingdon, UK). 105 tumor cells were incubated either with 0.5 μg of NKG2D Fc recombinant protein or IgG1-Fc during 30 min ...
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 complex was made with 1.5μg of recombinant human IL-2 (NIH) and 7.5μg of anti-human IL-2 (R&D Systems) per injection in 100μL of sterile PBS ...
-
bioRxiv - Physiology 2021Quote: ... recombinant mouse BMP4 Protein (R&D Systems, 5020-BP-010) [diluted in 0.1% BSA ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant mouse PD-1-Fc chimeric protein (R&D Systems) or human IgG1 control (R&D Systems) ...
-
bioRxiv - Microbiology 2023Quote: ... recombinant mouse Gas6 protein (R&D Systems, cat# 986-GS) (used in administration experiments in mice) ...
-
bioRxiv - Genetics 2023Quote: Recombinant Mouse IFNγ Protein (R&D Systems, 485-MI-100) was added to the NPC medium at a concentration of 10 ng/ml from day 0-5 ...
-
bioRxiv - Genetics 2023Quote: Recombinant Mouse IFNγ Protein (R&D Systems, 485-MI-100) was added to the iPSC medium at a concentration of 10 ng/ml from day 0-5 ...
-
bioRxiv - Immunology 2023Quote: ... recombinant mouse Fc-chimera proteins CD6 (rCD6, R&D Systems) and/or ICAM-1 (rICAM1 ...
-
bioRxiv - Microbiology 2020Quote: ... His6-tagged proteins were recognized with mouse anti-His6 (R&D systems MAB050). Biotinylated proteins were detected with Alexa-fluor-488-streptavidin (Molecular Probes S32354 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Glypican 1 (GPC-1) biotinylated antibody was purchased from R&D systems (MN, USA). Biotinylated anti-CD63 ...
-
bioRxiv - Developmental Biology 2019Quote: ... Both wild type and Adgrg6 KO ATDC5 cells were treated with 100ng/ml recombinant human IL-6 protein (rIL-6) (R&D System, 206-IL) for 2 hours before protein extraction.
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cancer Biology 2022Quote: ... +/-1 µg/mL anti-CD28 (CD28.2) antibody (eBioscience/Thermo 16-0289-81) or recombinant human CD58-Fc chimera protein (R&D Systems 10068-CD-050) at 37 ºC for 2 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... a mix of 10 μg/mL Laminin and 5 μg/mL of each SLRP protein (recombinant human CHAD (R&D Systems Cat#8218-CH), FMOD (R&D Systems Cat#9840-FM) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Experiments investigating EV-free AREG were undertaken by incubating recipient cells with 0.03 – 3000 ng/ml recombinant human Amphiregulin protein (R&D Systems #262-AR-100), for 30 minutes at 37°C before plating as described above.
-
bioRxiv - Bioengineering 2024Quote: ... 0.1% v/v FBS with or without 100 ng/ml Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN). Medium change was performed at day 3 and images were taken at 3 and 5 days using a Keyence BZ-X800 Fluorescence Microscope (Keyence ...
-
bioRxiv - Bioengineering 2024Quote: A total of 1 μg Cyr61 (Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) was dissolved in GelMA/fibrin hydrogel containing thrombin and transferred into a cylinder-shaped mold with a liquid capacity of 8.6 μl and 1 mm diameter with 1 mm thickness ...
-
bioRxiv - Bioengineering 2024Quote: ... Different concentrations of endogenous Cyr61 (0-200 ng/ml; Recombinant Human Cyr61/CCN1 Fc Chimera Protein, carrier-free; catalog no.: 4055-CR; R&D Systems, Minneapolis, MN) and TGFβ (0 or 10 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... counted and 5 μL/106 cells of Human EGFR (Research Grade Cetuximab Biosimilar) Alexa Fluor® 488-conjugated Antibody (R&D Systems) was added ...
-
bioRxiv - Cancer Biology 2021Quote: ... and human recombinant bFGF and EGF (25 ng/ml each; R&D Systems), hereafter ...
-
bioRxiv - Genetics 2021Quote: ... Stimulation was performed using 10 ng/ml recombinant human TGFβ1 (R&D system). C646 dissolved in DMSO was treated at a dose of 20 μM for 24 hours of pretreatment before TGFβ1 stimulation ...
-
bioRxiv - Cell Biology 2022Quote: ... 1.5 μg/mL recombinant human ICAM-1/CD54 Fc chimera (R&D systems) at 4° C ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.1 µM recombinant yeast or human GST-Uba1/UBE1 (E1, R&D Systems), 2.5 µM recombinant yeast or human ubiquitin (R&D Systems) ...
-
bioRxiv - Neuroscience 2019Quote: ... and human recombinant basic fibroblast growth factor (40 ng/ml; R&D Systems) on plates pre-coated with poly-l-ornithine (50 µg/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... and 10 ng/mL neuregulin-1 (recombinant human NRG-1; R&D Systems)) at 37°C in 5% CO2 ...
-
bioRxiv - Systems Biology 2021Quote: ... Recombinant human epidermal growth factor (EGF) was from R&D Systems (Abingdon, UK).
-
bioRxiv - Cancer Biology 2020Quote: ... 0.1 or 10 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany). Hyper-IL6 was a kind gift of Stefan Rose-John ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant human TGF-β1 and TGF-β2□was purchased from R&D Systems. miR-335 antagomirs were obtained from the following companies ...
-
bioRxiv - Cell Biology 2022Quote: Human recombinant TNFα was obtained from R&D Systems (Cat# 210-TA-020). Antibodies against Pink1 (6946S) ...
-
bioRxiv - Immunology 2022Quote: ... 2000ng/mL recombinant human (rh) IL32γ (4690-IL-025/CF, R&D Systems) or solvent control was given at the same time ...
-
bioRxiv - Neuroscience 2019Quote: ... 100ng/mL recombinant human fibroblast growth factor 8a (FGF-8a, R&D system) from day 2 to day 11 ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... and for the rhTrx group with recombinant human Thioredoxin-1 (R&D Systems; 2.5 mg/kg in 100 μL solution in 0.9% NaCl solution) ...
-
bioRxiv - Systems Biology 2020Quote: ... or recombinant human NRG-β1/HRG-β1 EGF domain (HRG; R&D Systems) for 5 min at 25°C ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human VEGFA165a and VEGFA165b were obtained from R&D Systems (Minneapolis, MN). Odyssey Blocking Buffer and an Odyssey Infrared Imager were purchased from LI-COR Biosciences (Lincoln ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant human RNF4 was purchased from R&D Systems (Cat. # E3-210-050). Recombinant human ubiquitin was purchased from R&D Systems (Cat ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Microbiology 2022Quote: ... the media contained 200 ng/mL of recombinant human IFNγ (R&D Systems). For M2 macrophages ...
-
bioRxiv - Neuroscience 2022Quote: ... Human recombinant IL-8 (catalog no. 208-IL-010, R&D Systems, USA) was used at a 5 ng/ml concentration ...
-
bioRxiv - Neuroscience 2023Quote: Exogenous IGF-1 Administration: Human recombinant IGF-1 (R&D Systems 291-G1) was reconstituted in sterile saline and 5µls (30µgSE ...
-
bioRxiv - Cancer Biology 2022Quote: ... and recombinant human IL-2 20 ng/ml (202-IL, R&D Systems). The QCM Leukocyte Migration Assay (MilliporeSigma ...
-
bioRxiv - Genetics 2023Quote: ... recombinant human EGF at 20 ng/mL (R&D systems #236-EG-200), and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant human (rh) TGF-β (10 ng/mL, R&D Systems, 7754-BH) was applied to NHLF cell line only to induce LOX expression ...